Navigation Links
Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
Date:9/28/2007

LAVAL, QC, Sept. 28 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. (NASDAQ.NEPT - TSX.V.NTB), is pleased to report its financial results for the fiscal year ended May 31, 2007. During the last fiscal year, Neptune improved its productivity and operational profitability while continuing its business development strategy to penetrate the American, European and Asian markets, resulting in sustainable sales growth.

Financial Results and Highlights:

- Sales increased by 18% to $8,126,000 from $6,912,000 in the preceding

fiscal year.

- EBITDA increased by 43% to $1,504,000 from $1,049,000 in the preceding

fiscal year, representing a third consecutive year with a positive

EBITDA.

- EBITDA margin reached 18.5%, compared to 15.2% in the preceding fiscal

year.

- Excluding stock-based compensation expenses, Neptune would have

realized earnings of $152,000 instead of a loss of $2,677,000 in the

fiscal year ended May 31, 2007. Excluding stock-based compensation

expenses and an extraordinary gain from the settlement of debentures,

Neptune would have realized a loss of $1,574,000 instead of a loss of

$886,000 in the fiscal year ended May 31, 2006.

"We believe that the evaluation model and accounting method for stock-based compensation expenses are not appropriate for small capitalization fast growing companies. They do not bring the accounting value of stock-based compensation closer to the market value, as they should and as they were implemented for", stated Xavier Harland, Director of Finance.

"Neptune has managed to increase its EBITDA by $455,000 with a $1.2M increase in sales, confirming its improvement in operational efficiency", stated Andre Godin, Vice-President, Administration and Finance.

Neptune continues to strongly support its strategic development plan to pursue partnerships/strategic alliances with worldwide leaders in
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...of Financial Executives International , a 15,000-...emics, and audit committee members, has announced ...community influence. , ,The group offers an opport...about the ethics, highest standards, and best prac...t the business dynamics of the Madison area are di...
...ates Air Force contract to fund the development of...vide a Madison aerospace research and product deve...ld enable it to propel something much larger. , ,T...d $3.9 million to Orbital Technologies Corp. (Or...le, but it might issue additional delivery orders ...
...mn by Geoff Bastow , will dissect topics that i... community, including: entrepreneurship in IT, in...nd technology trends that are driving real busine...kee, Wis. - At the dawn of the dot-com era and t...March of 2000, Kenosha entrepreneur John Weiss was...
...classified contract from the defense sector, Plex...ered here, reported record revenues and earnings f...spite the closing of its manufacturing facility in...mpered, however, by forecasts of lower-than-expect...s stock price to fall by roughly one-third. , ,Rev...
Other Biology Technology:Orbitec will use $25 million Air Force contract to make small launch vehicle 2Leadership insights from co-founder of Yesmail 2Leadership insights from co-founder of Yesmail 3Leadership insights from co-founder of Yesmail 4Leadership insights from co-founder of Yesmail 5Defense contract helps Plexus gain record profits 2
(Date:7/25/2008)...en born with hydrocephalus, or "water on the brain...ay from the brain to reduce harmful pressure. , ... infection in children is very high for a variety ...gh another surgery to replace the shunt, bringing ...eurological complications and an increased risk of...
(Date:7/25/2008)...d ,green, can potentially contain a naturally occu...risk to public health according to a review paper ...rnal of the Science of Food and Agriculture (JSFA... the ,green, affected area is enough to eliminate ... also suggests that the levels of GA in potatoes c...
(Date:7/24/2008)...k up plants just as they do human athletes, but th...s to boost growth and development in plant cells i...lls. A new study by plant biologists at the Carneg... called proteomics to identify key links in the st...nt hormones activate genes could lead not only to ...
(Date:7/24/2008)...rus called cytomegalovirus (CMV), which most commo..., can also affect hospital intensive-care patients... Washington researchers have found. CMV infection ...ive-care unit (ICU) stays independent of other cau... JAMA , the Journal of the American Medical Assoc...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Plant steroids offer new paradigm for how hormones work 2Plant steroids offer new paradigm for how hormones work 3CMV infections affect more than just patients with compromised immune systems, researchers find 2TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 1TAX ALERT 3A Deductions for Long Term Care Insurance Premiums 14532 2Ingenuity Systems Extends Enterprise Level Software Agreement With GlaxoSmithKline 4029 1Ingenuity Systems Extends Enterprise Level Software Agreement With GlaxoSmithKline 4029 2Cell Therapeutics Inc 28CTI 29 Invest Northwest Presentation to be Webcast 4026 1Reducing HD risk naturally post menopause 14530 1Reducing HD risk naturally post menopause 14530 2
... made massive changes to the Earth,s landscape , ...andscape. But what was happening below the ice in ...s that it was a time of mass destruction as whole ...s scouring the sea floor. , In the past it has be...tinction by recolonising from nearby habitats that...
...n of airplanes from the Wright Brothers, first bip...he much earlier evolution of dinosaur flight, say ...ogist Sankar Chatterjee and retired aeronautical e...ur called Microraptor gui used a two-level, biplan...he early Cretaceous. Among the evidence for the ea...
...e of the tropics unfolds, scientists must explain ...to rapid human-population increase and environment...n the world increase, tropical forests are changin...ed, burned, logged, fragmented, and overhunted and...tered in insidious ways by global climatic and atm...
...suggests that restoring a gene often silenced in l...findings could lead to a new strategy for treating...own as WWOX, which is lost or silenced in a large ...east, ovary, prostate, bladder, esophagus and panc...tate University Comprehensive Cancer Center ? Arth...
Other Biology News:Seafloor creatures destroyed by ice action during ice ages 2Wright bros. upstaged! Dinos invented biplanes 2Wright bros. upstaged! Dinos invented biplanes 3Scientists must offer solutions for conserving tropical forests in a rapidly changing world 2Restoring silenced suppressor gene kills lung-cancer cells 2
...1301 mutS are mismatch repair minus strains of E. ...newly synthesized unmethylated strand (1), leading...pful in such systems as the GeneEditor and Altered... 71-18 mutS are recA+, therefore inserts containin...
Polaroid black & white positive, 3 x 4 inch pack film, ISO 3000/ 36 ASA DIN (20 expsures). For use in the Polaroid Direct Copy Camera (PHC34).
Request Info
SHEEP ANTI ECHIS OCCELATUS (VENOM)
Biology Products: